News of Note—Anthem will cover artificial pancreas; Takeda posts update on depression-monitoring smartwatch study

newspaper

> Anthem, the second-largest insurance company nationwide, will cover artificial pancreas systems. Drug Delivery Business News story

> Takeda and Cognition Kit reported strong compliance in 30-person trial investigating the use of the Apple Watch to monitor people with major depressive disorder. Release | Read more from FierceMedTech

> The FDA cleared Kaléo’s AUVI-Q 0.1 mg Auto-injector, the first and only epinephrine autoinjector designed to treat allergic reactions in infants and small children. Release

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Suggested Articles

The FDA has approved its first contact lens designed to effectively slow the progression of nearsightedness in children, starting in ages 8 to 12.

Novartis tapped Biofourmis to develop tracking programs for heart failure patients, as the latter acquired Biovotion, makers of clinical wearables.

Janssen is planning its first completely virtual clinical trial, using personal smartphones and wearable devices with no in-person site visits.